><title>References</title><ref id="JIT494C1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>T</given-names></name><name><surname>Murray</surname><given-names>M</given-names></name><name><surname>Wallengren</surname><given-names>K</given-names></name><name><surname>Alvarez</surname><given-names>GG</given-names></name><name><surname>Samuel</surname><given-names>EY</given-names></name><name><surname>Wilson</surname><given-names>D</given-names></name></person-group><article-title>The prevalence and drug sensitivity of tuberculosis among patients dying in hospital in KwaZulu-Natal, South Africa: a postmortem study</article-title><source>PLoS Med</source><year>2010</year><volume>7</volume><fpage>e1000296</fpage><pub-id pub-id-type="pmid">20582324</pub-id></element-citation></ref><ref id="JIT494C2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>JA</given-names></name><name><surname>Lukande</surname><given-names>RL</given-names></name><name><surname>Lucas</surname><given-names>S</given-names></name><name><surname>Nelson</surname><given-names>AM</given-names></name><name><surname>Van Marck</surname><given-names>E</given-names></name><name><surname>Colebunders</surname><given-names>R</given-names></name></person-group><article-title>Autopsy causes of death in HIV-positive individuals in sub-Saharan Africa and correlation with clinical diagnoses</article-title><source>AIDS Rev</source><year>2010</year><volume>12</volume><fpage>183</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">21179183</pub-id></element-citation></ref><ref id="JIT494C3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rana</surname><given-names>FS</given-names></name><name><surname>Hawken</surname><given-names>MP</given-names></name><name><surname>Mwachari</surname><given-names>C</given-names></name><etal/></person-group><article-title>Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya</article-title><source>J Acquir Immune Defic Syndr</source><year>2000</year><volume>24</volume><fpage>23</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">10877491</pub-id></element-citation></ref><ref id="JIT494C4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walzl</surname><given-names>G</given-names></name><name><surname>Ronacher</surname><given-names>K</given-names></name><name><surname>Hanekom</surname><given-names>W</given-names></name><name><surname>Scriba</surname><given-names>TJ</given-names></name><name><surname>Zumla</surname><given-names>A</given-names></name></person-group><article-title>Immunological biomarkers of tuberculosis</article-title><source>Nat Rev Immunol</source><year>2011</year><volume>11</volume><fpage>343</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">21475309</pub-id></element-citation></ref><ref id="JIT494C5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawn</surname><given-names>SD</given-names></name><name><surname>Zumla</surname><given-names>AI</given-names></name></person-group><article-title>Tuberculosis</article-title><source>Lancet</source><year>2011</year><volume>378</volume><fpage>57</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">21420161</pub-id></element-citation></ref><ref id="JIT494C6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rangaka</surname><given-names>MX</given-names></name><name><surname>Wilkinson</surname><given-names>KA</given-names></name><name><surname>Glynn</surname><given-names>JR</given-names></name><etal/></person-group><article-title>Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis</article-title><source>Lancet Infect Dis</source><year>2012</year><volume>12</volume><fpage>45</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">21846592</pub-id></element-citation></ref><ref id="JIT494C7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samandari</surname><given-names>T</given-names></name><name><surname>Agizew</surname><given-names>TB</given-names></name><name><surname>Nyirenda</surname><given-names>S</given-names></name><etal/></person-group><article-title>6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial</article-title><source>Lancet</source><year>2011</year><volume>377</volume><fpage>1588</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">21492926</pub-id></element-citation></ref><ref id="JIT494C8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawn</surname><given-names>SD</given-names></name><name><surname>Wood</surname><given-names>R</given-names></name><name><surname>De Cock</surname><given-names>KM</given-names></name><name><surname>Kranzer</surname><given-names>K</given-names></name><name><surname>Lewis</surname><given-names>JJ</given-names></name><name><surname>Churchyard</surname><given-names>GJ</given-names></name></person-group><article-title>Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources</article-title><source>Lancet Infect Dis</source><year>2010</year><volume>10</volume><fpage>489</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">20610331</pub-id></element-citation></ref><ref id="JIT494C9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madhi</surname><given-names>SA</given-names></name><name><surname>Nachman</surname><given-names>S</given-names></name><name><surname>Violari</surname><given-names>A</given-names></name><etal/></person-group><article-title>Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children</article-title><source>N Engl J Med</source><year>2011</year><volume>365</volume><fpage>21</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">21732834</pub-id></element-citation></ref><ref id="JIT494C10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>MP</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><etal/></person-group><article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title><source>Nature</source><year>2010</year><volume>466</volume><fpage>973</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">20725040</pub-id></element-citation></ref><ref id="JIT494C11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maertzdorf</surname><given-names>J</given-names></name><name><surname>Repsilber</surname><given-names>D</given-names></name><name><surname>Parida</surname><given-names>SK</given-names></name><etal/></person-group><article-title>Human gene expression profiles of susceptibility and resistance in tuberculosis</article-title><source>Genes Immun</source><year>2011</year><volume>12</volume><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">20861863</pub-id></element-citation></ref><ref id="JIT494C12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname><given-names>RS</given-names></name><name><surname>Sabin</surname><given-names>FR</given-names></name><name><surname>Sugiyama</surname><given-names>S</given-names></name><name><surname>Kindwall</surname><given-names>JA</given-names></name></person-group><article-title>The role of the monocyte in tuberculosis</article-title><source>Bull Johns Hopkins Hosp</source><year>1925</year><volume>XXXVII</volume><fpage>231</fpage><lpage>80</lpage></element-citation></ref><ref id="JIT494C13"><label>13</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Sabin</surname><given-names>FR</given-names></name><name><surname>Doan</surname><given-names>CA</given-names></name><name><surname>Cunningham</surname><given-names>RS</given-names></name></person-group><article-title>Studies of the blood in experimental tuberculosis: the monocyte-lymphocyte ratio; the anemia-leucopenia phase</article-title><year>1926</year><conf-name>Trans 22nd Annu Meeting Natl Tuberc Assoc</conf-name><fpage>252</fpage><lpage>6</lpage></element-citation></ref><ref id="JIT494C14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>PM</given-names></name></person-group><article-title>A study of the blood monocytes in children with tuberculosis</article-title><source>N Engl J Med</source><year>1928</year><volume>198</volume><fpage>740</fpage><lpage>49</lpage></element-citation></ref><ref id="JIT494C15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doan</surname><given-names>CA</given-names></name><name><surname>Sabin</surname><given-names>FR</given-names></name></person-group><article-title>The relation of the tubercle and the monocyte:lymphocte ratio to resistance and susceptibility in tuberculosis</article-title><source>J Exp Med</source><year>1930</year><volume>52</volume><fpage>113</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">19869744</pub-id></element-citation></ref><ref id="JIT494C16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naranbhai</surname><given-names>V</given-names></name><name><surname>Abdool Karim</surname><given-names>Q</given-names></name><name><surname>Naidoo</surname><given-names>K</given-names></name><name><surname>Yende Zuma</surname><given-names>N</given-names></name><name><surname>Abdool Karim</surname><given-names>SS</given-names></name></person-group><article-title>Task-shifting for antiretroviral treatment is not only effective but also sustainable and improves over time</article-title><source>Lancet</source><year>2012</year><volume>380</volume><fpage>1907</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">23200500</pub-id></element-citation></ref><ref id="JIT494C17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdool Karim</surname><given-names>Q</given-names></name><name><surname>Abdool Karim</surname><given-names>SS</given-names></name><name><surname>Frohlich</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women</article-title><source>Science</source><year>2010</year><volume>329</volume><fpage>1168</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">20643915</pub-id></element-citation></ref><ref id="JIT494C18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdool Karim</surname><given-names>SS</given-names></name><name><surname>Naidoo</surname><given-names>K</given-names></name><name><surname>Grobler</surname><given-names>A</given-names></name><etal/></person-group><article-title>Timing of initiation of antiretroviral drugs during tuberculosis therapy</article-title><source>N Engl J Med</source><year>2010</year><volume>362</volume><fpage>697</fpage><lpage>706</lpage><pub-id pub-id-type="pmid">20181971</pub-id></element-citation></ref><ref id="JIT494C19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Loggerenberg</surname><given-names>F</given-names></name><name><surname>Mlisana</surname><given-names>K</given-names></name><name><surname>Williamson</surname><given-names>C</given-names></name><etal/></person-group><article-title>Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study</article-title><source>PLoS One</source><year>2008</year><volume>3</volume><fpage>e1954</fpage><pub-id pub-id-type="pmid">18414658</pub-id></element-citation></ref><ref id="JIT494C20"><label>20</label><element-citation publication-type="other"><collab>Republic of South Africa Department of Health of South Africa, Pretoria, South Africa</collab><article-title>South African National Antiretroviral Treatment Guidelines</article-title><year>2004</year></element-citation></ref><ref id="JIT494C21"><label>21</label><element-citation publication-type="other"><collab>Republic of South Africa Department of Health of South Africa, Pretoria, South Africa</collab><article-title>South African National Tuberculosis Management Guidelines</article-title><year>2009</year></element-citation></ref><ref id="JIT494C22"><label>22</label><element-citation publication-type="other"><collab>Republic of South Africa Department of Health of South Africa, Pretoria, South Africa</collab><article-title>South African National Antiretroviral Treatment Guidelines</article-title><year>2010</year></element-citation></ref><ref id="JIT494C23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdool Karim</surname><given-names>SS</given-names></name><name><surname>Naidoo</surname><given-names>K</given-names></name><name><surname>Grobler</surname><given-names>A</given-names></name><etal/></person-group><article-title>Integration of antiretroviral therapy with tuberculosis treatment</article-title><source>N Engl J Med</source><year>2011</year><volume>365</volume><fpage>1492</fpage><lpage>501</lpage><pub-id pub-id-type="pmid">22010915</pub-id></element-citation></ref><ref id="JIT494C24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawn</surname><given-names>SD</given-names></name><name><surname>Badri</surname><given-names>M</given-names></name><name><surname>Wood</surname><given-names>R</given-names></name></person-group><article-title>Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort</article-title><source>AIDS</source><year>2005</year><volume>19</volume><fpage>2109</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">16284460</pub-id></element-citation></ref><ref id="JIT494C25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dembele</surname><given-names>M</given-names></name><name><surname>Saleri</surname><given-names>N</given-names></name><name><surname>Carvalho</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso</article-title><source>Int J Tuberc Lung Dis</source><year>2010</year><volume>14</volume><fpage>318</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">20132623</pub-id></element-citation></ref><ref id="JIT494C26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seyler</surname><given-names>C</given-names></name><name><surname>Toure</surname><given-names>S</given-names></name><name><surname>Messou</surname><given-names>E</given-names></name><name><surname>Bonard</surname><given-names>D</given-names></name><name><surname>Gabillard</surname><given-names>D</given-names></name><name><surname>Anglaret</surname><given-names>X</given-names></name></person-group><article-title>Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan</article-title><source>Am J Respir Crit Care Med</source><year>2005</year><volume>172</volume><fpage>123</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15805184</pub-id></element-citation></ref><ref id="JIT494C27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carpenter</surname><given-names>E</given-names></name><name><surname>Fray</surname><given-names>L</given-names></name><name><surname>Gormley</surname><given-names>E</given-names></name></person-group><article-title>Cellular responses and Mycobacterium bovis BCG growth inhibition by bovine lymphocytes</article-title><source>Immunol Cell Biol</source><year>1997</year><volume>75</volume><fpage>554</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">9492191</pub-id></element-citation></ref><ref id="JIT494C28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denis</surname><given-names>M</given-names></name><name><surname>Wedlock</surname><given-names>DN</given-names></name><name><surname>Buddle</surname><given-names>BM</given-names></name></person-group><article-title>Ability of T cell subsets and their soluble mediators to modulate the replication of Mycobacterium bovis in bovine macrophages</article-title><source>Cell Immunol</source><year>2004</year><volume>232</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15922710</pub-id></element-citation></ref><ref id="JIT494C29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tobin</surname><given-names>DM</given-names></name><name><surname>Roca</surname><given-names>FJ</given-names></name><name><surname>Oh</surname><given-names>SF</given-names></name><etal/></person-group><article-title>Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections</article-title><source>Cell</source><year>2012</year><volume>148</volume><fpage>434</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">22304914</pub-id></element-citation></ref><ref id="JIT494C30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casadevall</surname><given-names>A</given-names></name><name><surname>Pirofski</surname><given-names>LA</given-names></name></person-group><article-title>The damage-response framework of microbial pathogenesis</article-title><source>Nat Rev Microbiol</source><year>2003</year><volume>1</volume><fpage>17</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">15040176</pub-id></element-citation></ref><ref id="JIT494C31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merekoulias</surname><given-names>G</given-names></name><name><surname>Alexopoulos</surname><given-names>EC</given-names></name><name><surname>Belezos</surname><given-names>T</given-names></name><name><surname>Panagiotopoulou</surname><given-names>E</given-names></name><name><surname>Jelastopulu</surname><given-names>DM</given-names></name></person-group><article-title>Lymphocyte to monocyte ratio as a screening tool for influenza</article-title><source>PLoS Curr</source><year>2010</year><volume>2</volume><fpage>RRN1154</fpage><pub-id pub-id-type="pmid">20383263</pub-id></element-citation></ref><ref id="JIT494C32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller-Sieburg</surname><given-names>CE</given-names></name><name><surname>Cho</surname><given-names>RH</given-names></name><name><surname>Thoman</surname><given-names>M</given-names></name><name><surname>Adkins</surname><given-names>B</given-names></name><name><surname>Sieburg</surname><given-names>HB</given-names></name></person-group><article-title>Deterministic regulation of hematopoietic stem cell self-renewal and differentiation</article-title><source>Blood</source><year>2002</year><volume>100</volume><fpage>1302</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">12149211</pub-id></element-citation></ref><ref id="JIT494C33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname><given-names>WW</given-names></name><name><surname>Price</surname><given-names>EA</given-names></name><name><surname>Sahoo</surname><given-names>D</given-names></name><etal/></person-group><article-title>Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age</article-title><source>Proc Natl Acad Sci U S A</source><year>2011</year><volume>108</volume><fpage>20012</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">22123971</pub-id></element-citation></ref><ref id="JIT494C34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schroeder</surname><given-names>T</given-names></name></person-group><article-title>Hematopoietic stem cell heterogeneity: subtypes, not unpredictable behavior</article-title><source>Cell Stem Cell</source><year>2010</year><volume>6</volume><fpage>203</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">20207223</pub-id></element-citation></ref><ref id="JIT494C35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller-Sieburg</surname><given-names>CE</given-names></name><name><surname>Sieburg</surname><given-names>HB</given-names></name><name><surname>Bernitz</surname><given-names>JM</given-names></name><name><surname>Cattarossi</surname><given-names>G</given-names></name></person-group><article-title>Stem cell heterogeneity: implications for aging and regenerative medicine</article-title><source>Blood</source><year>2012</year><volume>119</volume><fpage>3900</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">22408258</pub-id></element-citation></ref><ref id="JIT494C36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baldridge</surname><given-names>MT</given-names></name><name><surname>King</surname><given-names>KY</given-names></name><name><surname>Boles</surname><given-names>NC</given-names></name><name><surname>Weksberg</surname><given-names>DC</given-names></name><name><surname>Goodell</surname><given-names>MA</given-names></name></person-group><article-title>Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection</article-title><source>Nature</source><year>2010</year><volume>465</volume><fpage>793</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">20535209</pub-id></element-citation></ref><ref id="JIT494C37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>B</given-names></name><name><surname>Kashino</surname><given-names>SS</given-names></name><name><surname>Pulu</surname><given-names>I</given-names></name><etal/></person-group><article-title>CD271+ bone marrow mesenchymal stem cells may provide a niche for dormant Mycobacterium tuberculosis</article-title><source>Sci Transl Med</source><year>2013</year><volume>5</volume><comment>170ra13-ra13</comment></element-citation></ref><ref id="JIT494C38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gideon</surname><given-names>HP</given-names></name><name><surname>Flynn</surname><given-names>JL</given-names></name></person-group><article-title>Latent tuberculosis: what the host &#x0201c;sees&#x0201d;?</article-title><source>Immunol Res</source><year>2011</year><volume>50</volume><fpage>202</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">21717066</pub-id></element-citation></ref><ref id="JIT494C39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>K</given-names></name></person-group><article-title>Effect of tuberculin test on monocyte-lymphocyte ratio in children</article-title><source>J Pediatr</source><year>1935</year><volume>7</volume><fpage>238</fpage><lpage>44</lpage></element-citation></ref><ref id="JIT494C40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warimwe</surname><given-names>GM</given-names></name><name><surname>Murungi</surname><given-names>LM</given-names></name><name><surname>Kamuyu</surname><given-names>G</given-names></name><etal/></person-group><article-title>The ratio of monocytes to lymphocytes in peripheral blood correlates with increased susceptibility to clinical malaria in Kenyan children</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><fpage>e57320</fpage><pub-id pub-id-type="pmid">23437368</pub-id></element-citation></ref></